Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP).

Michelle CespedesMoupali Das J Carlo HojillaJill BlumenthalKaram MounzerMoti RamgopalTheo HodgeThiago S TorresCharles PetersonSenzokuhle ShibaseAyana ElliottA C DemidontLarkin CallaghanC Chauncey WatsonChristoph CarterAlex KintuJared M BaetenOnyema Ogbuagu

Published in: PloS one (2022)

Clinical Trial Number: NCT04925752.

Keyphrases

hiv testing
men who have sex with men
clinical trial
phase ii
hiv positive
phase iii
study protocol
open label
social media
antiretroviral therapy
double blind
randomized controlled trial
human immunodeficiency virus
placebo controlled
hiv aids
south africa